DIA515.52+0.63 0.12%
SPY746.74+7.68 1.04%
QQQ740.62+18.11 2.51%

BioDlink proposes auditor switch to Deloitte from PwC

PUBT·06/04/2026 13:50:44
Listen to the news
BioDlink proposes auditor switch to Deloitte from PwC
  • TOT BIOPHARM International will replace PwC with Deloitte Touche Tohmatsu as auditor for the year ended Dec. 31, 2026.
  • PwC will retire at the conclusion of the June 26, 2026 annual general meeting; shareholders will vote on Deloitte’s appointment.
  • Estimated 2026 audit fee: RMB 2.7 million, including RMB 2.2 million for audit services.
  • The board cited auditor rotation and expected gains in audit efficiency, communication, and cost control.
  • The board flagged no disputes with PwC; no expected impact on the 2026 annual audit timetable or results release.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TOT BIOPHARM International Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260604-12191057), on June 04, 2026, and is solely responsible for the information contained therein.

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.